Peter DeNardis | CureTalks
When Peter DeNardis was diagnosed with Waldenstrom’s macroglobulinema in 2003 at the age of 43, he found support through the International Waldenstrom’s Macroglobulinemia Foundation (IWMF), a nonprofit providing information, support and resources to patients with WM. At the time, treatment options were limited, and he was given seven years to live. Fortunately, the IWMF and the medical community have since helped develop newer and better forms of treatment, and he is able to maintain a busy schedule. While working full time as a university financial systems administrator and adjunct IT professor, and dealing with intermittent periods of remission and relapse, he also has been very active as a volunteer with the IWMF over the years and currently serves as the Chair of their Board of Trustees. He lives in Hopewell Township, Pennsylvania, with his wife, Terri, and their three adult children and their partners live nearby. Besides his “day job” and volunteer work for the IWMF, he can also be found tending to his wine making hobby and babysitting two new grandchildren.
Related Talks
Diagnosis and Management of Waldenstrom’s Macroglobulinemia
Waldenstrom's macroglobulinemia (WM) is a rare type of cancer that begins in the white blood cells.The abnormal white blood cells produce a protein…
Waldenstrom’s Macroglobulinemia: Advances in Treatments
Waldenstrom’s macroglobulinemia (WM) is a lymphoma, or cancer of the lymphatic system. The disease begins in a type of white blood cell called…